Zynex Ownership
| ZYXI Stock | USD 2.37 0.27 12.86% |
Zynex Stock Ownership Analysis
About 48.0% of the company outstanding shares are owned by insiders. The book value of Zynex was at this time reported as 0.69. The company recorded a loss per share of 0.27. Zynex Inc last dividend was issued on the 5th of January 2022. The entity had 11:10 split on the 5th of January 2022. Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people. For more information please call Thomas Sandgaard at 303 703 4906 or visit https://www.zynex.com.Zynex Inc Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zynex insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zynex's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zynex insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zynex Outstanding Bonds
Zynex issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zynex Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zynex bonds can be classified according to their maturity, which is the date when Zynex Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US98981BAA08 Corp BondUS98981BAA08 | View | |
| US98980BAA17 Corp BondUS98980BAA17 | View |
Currently Active Assets on Macroaxis
When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zynex Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.